Literature DB >> 687540

Transfer of digoxin across the placenta and into breast milk.

V Chan, T F Tse, V Wong.   

Abstract

Eleven mothers given digoxin throughout pregnancy because of rheumatic heart disease were studied. Digoxin was identified in the placenta and, for the first time, in milk. Paired cord and maternal blood samples obtained at parturition showed lower digoxin levels in cord blood than in maternal blood. The total tissue-bound digoxin level in the placenta correlated closely with maternal digoxin levels. These findings suggest strongly the presence of a placental barrier for digoxin. Similar digoxin concentrations (0.825 +/- 0.015 nmol/l) were found in milk samples obtained daily between the third and seventh days post partum. The half-life of digoxin in the newborn was 36.2 +/- 5.43 hours (Mean +/- SEM); thus all the digoxin present at birth would be excreted within 10 to 11 days.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 687540     DOI: 10.1111/j.1471-0528.1978.tb14929.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  15 in total

Review 1.  Drug treatment of fetal tachycardias.

Authors:  Martijn A Oudijk; Jopje M Ruskamp; Barbara E Ambachtsheer; Tessa F F Ververs; Philip Stoutenbeek; Gerard H A Visser; Erik J Meijboom
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 2.  Treatment of cardiac arrhythmias during pregnancy: safety considerations.

Authors:  J A Joglar; R L Page
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 3.  The pediatric cardiology pharmacopeia: 2013 update.

Authors:  Paul Nicholas Severin; Sawsan Awad; Beth Shields; Joan Hoffman; William Bonney; Edmundo Cortez; Rani Ganesan; Aloka Patel; Steve Barnes; Sean Barnes; Shada Al-Anani; Umang Gupta; Yolandee Bell Cheddar; Ismael E Gonzalez; Kiran Mallula; Hani Ghawi; Suhaib Kazmouz; Salwa Gendi; Ra-id Abdulla
Journal:  Pediatr Cardiol       Date:  2012-11-29       Impact factor: 1.655

4.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

5.  Prediction of drug concentrations in human skim milk from plasma protein binding and acid-base characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of digoxin 1980.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

Review 7.  Placental transfer of drugs administered to the mother.

Authors:  G M Pacifici; R Nottoli
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

Review 8.  Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

Authors:  J T Wilson; R D Brown; D R Cherek; J W Dailey; B Hilman; P C Jobe; B R Manno; J E Manno; H M Redetzki; J J Stewart
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

Review 9.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

Review 10.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.